Acute activation of peripheral lymphocytes during treatment of diabetic ketoacidosis

Journal of Diabetes and its Complications

Volumn 15, Issue 3, 2001, Pages 144-149

  Hoffman, William H ^a   Helman, Sandra W ^a   Passmore, Gregory ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

Diabetic ketoacidosis; Leukocytosis; Lymphocyte activation

Indexed keywords

HLA DR ANTIGEN;

ADULT; ARTICLE; BLOOD ANALYSIS; BLOOD PH; BRAIN EDEMA; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; DIABETIC KETOACIDOSIS; DISEASE COURSE; DISEASE SEVERITY; HOSPITAL ADMISSION; HUMAN; HUMAN CELL; HYPERGLYCEMIA; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; LUNG EDEMA; OSMOLALITY; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; SCHOOL CHILD; T LYMPHOCYTE ACTIVATION; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ANTIGENS, CD; BLOOD GLUCOSE; CHILD; DEHYDRATION; DIABETES MELLITUS, TYPE 1; DIABETIC KETOACIDOSIS; ELECTROLYTES; FLOW CYTOMETRY; HLA-DR ANTIGENS; HUMANS; HYDROGEN-ION CONCENTRATION; HYPERGLYCEMIA; HYPERTENSION; LYMPHOCYTE ACTIVATION; T-LYMPHOCYTES; TIME FACTORS;

EID: 0035018328     PISSN: 10568727     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1056-8727(00)00142-2     Document Type: Article

References (59)

1. Abramowicz D., Schandene L., Goldman M., Crusiaux A., Vereerstraeten P., DePauw L., Wybran J., Kinnaert P., Dupont I., Toussaint C. Release of tumor necrosis factor, interleukin-2 and gamma interferon in serum after injection of OKT3 monoclonal antibody in kidney transplant recipients. Transplantation. 47:1989;606-608.
2. Allende L.M., Corell A., Mauzanares J., Madruga D., Marcos A., Madrono A., Lopez-Goyanes A., Garcia-Perez M.A., Moreno J.M., Rodrigo M., Sanz F., Arnaiz-Villena A. Immunodeficiency associated with anorexia nervosa is secondary and improves after refeeding. Immunology. 94:1998;543-551.
3. Almawi W.Y., Tamim H., Azar S.T. T Helper Type 1 and 2 cytokines mediate the onset and progression of Type 1 (insulin-dependent) diabetes. Journal of Clinical Endocrinology and Metabolism. 84:1999;1497-1502.
4. Andrade-Mena C.E. Inhibition of gamma interferon synthesis by catecholamines. Journal of Neuroimmunology. 76:1997;10-14.
5. Arva E., Anderson B. Kinetics of cytokine release and expression of lymphocyte cell-surface activation markers after in vitro stimulation of human peripheral blood mononuclear cells with Streptococcus pneumoniae. Scandinavian Journal of Immunology. 49:1999;237-243.
6. Athens J.W., Haab O.P., Raab S.O., Mauer A.M., Ashenbrucker H., Cartwright G.E., Wintrobe M.M. Leukokinetic studies: IV. The total blood, circulating and marginal granulocyte pools and the granulocytes turnover rate in normal subjects. Journal of Clinical Investigation. 40:1961;989-996.
7. Benschop R.J., Rodriguez-Feuerhahn M., Schedlowski M. Catecholamine-induced leucocytosis: early observations, current research and future directions. Brain, Behavior, and Immunity. 10:1996;77-91.
8. Bottazzo G.F., Dean B.M., McNally J.M., Mackay E.H., Swift P.G.F., Gamble D.R. In situ characterization of autoimmune phenomena and expression of HLA molecules in the pancreas in diabetic insulitis. New England Journal of Medicine. 313:1985;353-360.
9. Burris A.S. Leukemoid reaction associated with severe diabetic ketoacidosis. Southern Medical Journal. 79:1986;647-648.
10. Carl G.F., Hoffman W.H., Blankenship P.R., Litaker M.S., Hoffman M.G., Mabe P.A. Diabetic ketoacidosis depletes plasma tryptophan. Diabetes Research. 34:1999;149-165.
11. Caruso A., Licenziati S., Corulli M., Canaris A.D., De Francesco M.A., Fiorentini, Peroni L., Fallacara F., Dima F., Balsari A., Turano A. Flow cytometric analysis of activation markers on stimulated T cells and their correlation with cell proliferation. Cytometry. 27:1997;71-76.
12. Chang R., Wong G.Y. Prognostic significance of marked leukocytosis in hospitalized patients. Journal of General Internal Medicine. 6:1991;199-203.
13. Cohen A.S., Vance V.K., Runyan J.W., Hurwitz D. Diabetic ketoacidosis: an evaluation of the cause, course and therapy of 73 cases. Annals of Internal Medicine. 52:1960;55-86.
14. Conrad B., Weidmann E., Trucco G., Rudert A., Belboo R., Ricordi C., Rodriguez-Rilo H., Finegold D., Trucco M. Evidence of superantigen involvement in insulin-dependent diabetes mellitus aetiology. Nature. 371:1994;351-355.
15. Cook-Mills J.M., Cohen R.L., Perlman R.L., Chambers D.A. Inhibition of lymphocyte activation by catecholamines: evidence for a non-classical mechanism of catecholamine action. Immunology. 85:1995;544-549.
16. Cotner T., Williams J.M., Christenson L., Shapiro H.M., Strom T.B., Strominger J. Simultaneous flow cytometric analyses of human T cell activation antigen expression and DNA content. Journal of Experimental Medicine. 157:1983;461-472.
17. Daly J.M., Reynolds J., Thom A., Kinsley L., Dietrick-Gallagher M., Show J., Ruggieri B. Immune and metabolic effects of arginine in the surgical patient. Annals of Surgery. 208:1988;512-521.
18. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. New England Journal of Medicine. 329:1993;977-986.
19. Deitch E.A., Bridges R.M. Stress hormones modulate neutrophil and lymphocyte activity in vitro. Journal of Trauma. 27:1987;1146-1154.
20. Doukas J., Mordes J.P. T-lymphocytes capable of activating endothelial cells in vitro are present in rats with autoimmune diabetes. Journal of Immunology. 150:1993;1036-1046.
21. Durr J.A., Hoffman W.H., Sklar A.H., El Gammal T., Steinhart C.M. Correlates of brain edema in uncontrolled IDDM. Diabetes. 41:1992;627-632.
22. Gessl A., Waldhausl W. Increased CD69 and human leucocyte antigen-DR expression on T lymphocytes in insulin-dependent diabetes mellitus of long standing. Journal of Clinical Endocrinology and Metabolism. 83:1998;2204-2209.
23. Hale P.M., Rezvaui I., Braunstein A.W., Lipman T.H., Martinez N., Garibaldi L. Factors predicting cerebral edema in young children with diabetic ketoacidosis and new onset type I diabetes. Acta Paediatrica. 86:1997;626-631.
24. Hanninen A., Jalkanen S., Salmi M., Toikkanen S., Nikolakaros G., Simell O. Macrophages, T cell receptor usage and endothelial cell activation in the pancreas at the onset of insulin-dependent diabetes mellitus. Journal of Clinical Investigation. 90:1992;1901-1910.
25. Hehmke B., Michaelis D., Gens E., Laube F., Kohnert K.-D. Aberrant activation of CD4+ T-cell and CD8+ T-cell subsets in patients with newly diagnosed IDDM. Diabetes. 44:1995;1414-1419.
26. Hoffman W.H., Locksmith J.P., Burton E.M., Hobbs E., Passmore G.G., Pearson-Shaver A.L., Deane D.A., Boudreaux M.M., Bassali R.W. Interstitial pulmonary edema in children and adolescents with diabetic ketoacidosis. Journal of Diabetes Complications. 12:1998;314-320.
27. Hoffman W.H., Steinhart M., El Gammal T., Steele S., Cuadrado A.R., Morse P.K. Cranial computed tomography in children and adolescents with diabetic ketoacidosis. Journal of Neuroradiology. 9:1998;733-739.
28. Hoffman W.H., Passmore G.G., Carl G.F., Truemper E.J., Lightsey A.L., Cornwell P.E., Jonah M.H. Anticoagulant and procoagulant factors prior to and during treatment of diabetic ketoacidosis. Diabetes Research. 34:1999;183-195.
29. Isales C.M., Min L., Hoffman W.H. Acetoacetate and β-hydroxybutyrate differentially regulate endothelin-1 and vascular endothelial growth factor in mouse brain microvascular endothelial cells. Journal of Diabetes Complications. 13:1999;91-97.
30. Itoh N., Hanafusa T., Miyazaki A., Miyagawa J., Yamagata K., Yamoto K., Waguri M., Imagawa A., Tamira S., Indada M., Kawata S., Tauri S., Kono N., Matsuzawa Y. Mononuclear cell infiltration and its relation to the expression of major histocompatibility complex antigens and adhesion molecules in pancreas biopsy specimens from newly diagnosed insulin-dependent diabetes mellitus patients. Journal of Clinical Investigation. 92:1993;2313-2322.
31. Jeyarajah D.R., Thislethwaite J.R. General aspects of cytokine-release syndrome: timing and incidence of symptoms. Transplantation Proceedings. 25(Suppl. 1):1993;16-20.
32. Junger W.G., Liu F.C., Loomis W.H., Hoyt D.B. Hypertonic saline enhances cellular immune function. Circulatory Shock. 42:1994;190-196.
33. Kayashima T., Yamagirchi K., Akiyoshi T., Nanimatsu H., Aragaki S., Hosokawa T. Leukemoid reaction associated with diabetic ketoacidosis - with measurement of plasma levels granulocyte colony-stimulating factor. Internal Medicine. 32:1993;869-871.
34. Koh W.S., Lee M., Yang K.H., Kaminski N.E. Expression of functional glucagon receptors on lymphoid cells. Life Science. 58:1986;741-751.
35. Kretowski A., Mysliwiec J., Szelachowska M., Kinalski M., Kinalska I. Insulin increases in vitro production of Th 2 profile cytokines in peripheral blood cultures in subjects at high risk of diabetes type 1 and patients with newly diagnosed IDDM. Hormone and Metabolic Research. 31:1999;289-292.
36. Kruimel J.W., Pesman G.J., Sweep C.G., vander Vliet J.A., Liem T., Jansen J.B., vander Meer J.W., Naber A.H. Depression of plasma levels of cytokines and ex vivo cytokine production in relation to the activity of the pituitary-adrenal axis in relation to patients undergoing major vascular surgery. Cytokine. 11:1999;382-388.
37. Mack F., Schonbeck U., Libby P. CD40 signaling in vascular cells: a key role in atherosclerosis? Atherosclerosis. 137:1998;589-595.
38. Morell V., Lundgren E., Gillott A. Predicting severity of trauma by admission white blood cell count, serum potassium level and arterial pH. Southern Medical Journal. 86:1993;658-659.
39. Munn D.H., Shafiqadeh E., Ahwood J.T., Bondarev I., Pashine A., Mellor A.L. Inhibition of T cell proliferation by macrophage tryptophan catabolism. Journal of Experimental Medicine. 189:1999;1363-1372.
40. Mustafa A., Ward A., Treasure J., Peakman M. T-lymphocyte subpopulations in anorexia nervosa and refeeding. Clinical Immunology and Immunopathology. 82:1997;282-289.
41. Ohashi T., Mori Y., Narimiya M., Yokoyama J., Ikeda Y., Isogai Y. Type I (insulin-dependent) diabetic patient with remarkable infiltration of lymphocytes to the islets. Endocrine Journal. 40:1993;633-639.
42. Peakman M., Leslie R.D.G., Alriggi L., Hawa M., Vergani D. Persistent activation of CD8+ T-cells characterize prediabetic twins. Diabetes Care. 11:1996;1177-1184.
43. Petersen L.D., Duinkerken G., Bruining G.J., van Lier R.A., de Vries R.R., Roep B.O. Increased numbers of in vivo activated T cells in patients with recent onset insulin-dependent diabetes mellitus. Journal of Autoimmunity. 9:1996;731-737.
44. Petersen L.D., van der Keur M., de Vries R.R., Roep B.O. Autoreactive and immunoregulatory T-cell subsets in insulin-dependent diabetes mellitus. Diabetologia. 42:1999;443-449.
45. Rosenbloom A.L. Intracerebral crises during treatment of diabetic ketoacidosis. Diabetes Care. 13:1999;22-33.
46. Sato S., Suzuki T., Okada K. Suppression of mitogenic response of bovine peripheral blood lymphocytes by ketone bodies. Journal of Veterinary Medical Science. 57:1995;183-185.
47. Schlott N.C., Roep B.O., Wegmann D., Yu L., Chase H.P., Want T., Eisenbarth G.S. Altered immune response to insulin in newly diagnosed compared to insulin treated diabetic patients and healthy control subjects. Diabetologia. 40:1997;564-572.
48. Schmitt W.H., Csernok E., Kobayaski S., Klinkenborg A., Reinhold-Keller E., Gross W.L. Churg-Strauss syndrome. Arthritis & Rheumatism. 41:1998;445-452.
49. Shapiro L., Dinarello C.A. Hyperosmotic stress as a stimulate for proinflammatory cytokine production. Experimental Cell Research. 231:1997;354-362.
50. Shi H.Z., Sun J.J., Pan H.L., Lu J.Q., Zhang J.L., Jiang J.D. Alternations of T-lymphocyte subsets, soluble IL-2 receptor and IgE in peripheral blood of children with acute asthma attacks. Journal of Allergy and Clinical Immunology. 103:1999;388-394.
51. Shimaoka M., Hosotsubo K., Sugimoto M., Sakaue G., Taenaka N., Yoshiya I., Kiyono H. The influence of surgical stress on T cells: enhancement of early phase lymphocyte activation. Anesthesia & Analgesia. 87:1998;1431-1435.
52. Silver S.M., Clark E.C., Schroeder B.M., Sterns R.H. Pathogenesis of cerebral edema after treatment of diabetic ketoacidosis. Kidney International. 51:1997;1237-1244.
53. Speert D.P., Silva J. Abnormalities of in-vitro lymphocyte response to mitogens in diabetic children during acute ketoacidosis. American Journal of Diseases of Children. 132:1978;1014-1017.
54. Tang S., Le-Ruppert K.C. Activated T lymphocytes in epiretinal membranes from eyes of patients with proliferative diabetic retinopathy. Graefe's Archive for Clinical and Experimental Ophthalmology. 233:1995;21-25.
55. Tang S., Scheiffarth O.F., Thurau S.R., Wildner G. Cells of the immune system and their cytokines in epiretinal membranes and in the vitreous of patients with proliferative diabetic retinopathy. Ophthalmic Research. 25:1993;177-185.
56. Targowski S.P., Klucinski W. Reduction in mitogenic response of bovine lymphocytes by ketone bodies. American Journal of Veterinary Research. 44:1983;828-830.
57. Wilckens T., De Rijk R. Glucocorticoids and immune function: unknown dimensions and new frontiers. Immunology Today. 18:1997;418-424.
58. Wong D., Prameya R., Dorovini-Zis K. In vitro adhesion and migration of T-lymphocytes across monolayers of human brain microvessel endothelial cells: regulation by ICAM-1, VCAM-1, E-selection and PECAM-1. Journal of Neuropathology and Experimental Neurology. 58:1999;138-152.
59. Younger D.S., Rosoklija G., Hays A.P., Jrojaborg W., Latov N. Diabetic peripheral neuropathy: a clinicopathologic and immunohistochemical analysis of sural nerve biopsies. Muscle & Nerve. 19:1996;722-727.